Modulation of pulmonary innate immunity during bacterial infection: Animal studies

Archivum Immunologiae et Therapiae Experimentalis

Volumn 50, Issue 3, 2002, Pages 159-167

  Schultz, Marcus J ^a,b   Van Der Poll, Tom ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Alveolar macrophages; Cytokines; Immunotherapy; Innate immunity; Pneumonia

Indexed keywords

CYTOKINE;

ANIMAL; BACTERIAL PNEUMONIA; ENTEROBACTER INFECTION; GRAM NEGATIVE INFECTION; IMMUNOLOGY; INNATE IMMUNITY; LEGIONNAIRE DISEASE; LOBAR PNEUMONIA; LUNG; LUNG ALVEOLUS MACROPHAGE; MYCOPLASMA PNEUMONIA; PHYSIOLOGY; REVIEW;

ANIMALS; CYTOKINES; IMMUNITY, NATURAL; KLEBSIELLA INFECTIONS; LEGIONNAIRES' DISEASE; LUNG; MACROPHAGES, ALVEOLAR; PNEUMONIA, BACTERIAL; PNEUMONIA, MYCOPLASMA; PNEUMONIA, PNEUMOCOCCAL; PSEUDOMONAS INFECTIONS;

EID: 0041366927     PISSN: 0004069X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (68)

1. AMURA C. R., FONTAN P. A., SANJUAN N., NOCIARI M. M., BUZZOLA F. R. and SORDELLI D. O. (1995): Tumor necrosis factor a plus interleukin 1β treatment protects granulocytopenic mice from Pseudomonas aeruginosa lung infection: role of an unusual inflammatory response. APMIS, 103, 447-459.
2. AMURA C. R., FONTAN P. A., SANJUAN N. and SORDELLI D. O. (1994): The effect of treatment with interleukin-1 and tumor necrosis factor on Pseudomonas aeruginosa lung infection in a granulocytopenic mouse model. Clin. Immunol. Immunopathol., 73, 261-266.
3. BEUTLER B. (1995): TNF, immunity and inflammatory disease: lessons of the past decade. J. Invest. Med., 43, 227-235.
4. BOEHM U., KLAMP T., GROOT M. and HOWARD J. C. (1997): Cellular responses to interferon-γ. Annu. Rev. Immunol., 15, 749-795.
5. BOUTTEN A., DEHOUX M. S., SETA N., OSTINELLI J., VENEMBRE P., CRESTANI B., DOMBRET M. C., DURAND G. and AUBIER M. (1996): Compartmentalized IL-8 and elastase release within the human lung in unilateral pneumonia. Am. J. Respir. Crit. Care Med., 153, 336-342.
6. BRIELAND J. K., REMICK D. G., FREEMAN P. T., HURLEY M. C., FANTONE J. C. and ENOLEBERG N. C. (1995): In vivo regulation of replicative Legionella pneumophila lung infection by endogenous tumor necrosis factor a and nitric oxide. Infect. Immun., 63, 3253-3258.
7. BRIELAND J. K., REMICK D. G., LEGENDRE M. L., ENGLEBERG N. C. and FANTONE J. C. (1998): In vivo regulation of replicative Legionella pneumophila lung infection by endogenous interleukin-12. Infect. Immun., 66, 65-69.
8. BROADDUS V. C., HEBERT C. A., VITANGCOL R. V., HOEFFEL J. M., BERNSTEIN M. S. and BOYLAN A. M. (1992): Interleukin-8 is a major neutrophil chemotactic factor in pleural liquid of patients with empyema. Am. Rev. Respir. Dis., 146, 825-830.
9. BROUG-HOLUB E. and KRAAL G. (1997): In vivo study on the immunomodulating effects of OM-85 BV on survival, inflammatory cell recruitment and bacterial clearance in Klebsiella pneumonia. Int. J. Immunopharmacol., 19, 559-564.
10. CHEUNG D. O., HALSEY K. and SPEERT D. P. (2000): Role of pulmonary alveolar macrophages in defense of the lung against Pseudomonas aeruginosa. Infect. Immun., 68, 4585-4592.
11. Cox G. (1996): IL-10 enhances resolution of pulmonary inflammation in vivo by promoting apoptosis of neutrophils. Am. J. Physiol., 271, L566-L571.
12. Cox G., CROSSLEY J. and XING Z. (1995): Macrophage engulfment of apoptotic neutrophils contributes to the resolution of acute pulmonary inflammation in vivo. Am. J. Respir. Cell. Mol. Biol., 12, 232-237.
13. DEHOUX M. S., BOUTTEN A., OSTINELLI J., SETA N., DOMBRET M. C., CRESTANI B., DESCHENES M., TROUILLET J. L. and AUBIER M. (1994): Compartmentalized cytokine production within the human lung in unilateral pneumonia. Am. J. Respir. Crit. Care Med., 150, 710-716.
14. DENG J., TATEDA K., ZENG X. and STANDIFORD T. (2001): Transient transgenic expression of γ-interferon promotes Legionella pneumophila clearance in ummunocompetent hosts. J. Immunol., 69, 6382-6390.
15. DINARELLO C. A. (1996): Biologic basis for interleukin-1 in disease. Blood, 87, 2095-2147.
16. FADOK V. A., BRATTON D. L., GUTHRIE L. and HENSON P. M. (2001): Differential effects of apoptotic versus lysed cells on macrophage production of cytokines: role of proteases. J. Immunol., 166, 6847-6854.
17. FADOK V. A., BRATFON D. L., ROSE D. M., PEARSON A., EZEKEWITZ R. A. and HENSON P. M. (2000): A receptor for phosphatidylserine-specific clearance of apoptotic cells. Nature, 405, 85-90.
18. FADOK V. A., SAVILL J. S., HASLETT C., BRATTON D. L., DOHERTY D. E., CAMPBELL P. A. and HENSON P. M. (1992): Different populations of macrophages use either the vitronectin receptor or the phosphatidylserine receptor to recognize and remove apoptotic cells. J. Immunol., 149, 4029-4035.
19. GOSSELIN D., DESANCTIS J., BOULE M., SKAMENE E., MATOUK C. and RADZIOCH D. (1995): Role of tumor necrosis factor a in innate resistance to mouse pulmonary infection with Pseudomonas aeruginosa. Infect. Immun., 63, 3272-3278.
20. GREENBERGER M. J., KUNKEL S. L., STRIETER R. M., LUKACS N. W., BRAMSON J., GAULDIE J., GRAHAM F. L., HITT M., DANFORTH J. M. and STANDIFORD T. J. (1996): IL-12 gene therapy protects mice in lethal Klebsiella pneumonia. J. Immunol., 157, 3006-3012.
21. GREENBERGER M. J., STRIETER R. M., KUNKEL S. L., DANFORTH J. M., GOODMAN R. E. and STANDIFORD T. J. (1995): Neutralization of IL-10 increases survival in a murine model of Klebsiella pneumonia. J. Immunol., 155, 722-729.
22. GREENBERGER M. J., STRIETER R. M., KUNKEL S. L., DANFORTH J. M., LAICHALK L. L., MCGILLICUDDY D. C. and STANDIFORD T. J. (1996): Neutralization of macrophage inflammatory protein-2 attenuates neutrophil recruitment and bacterial clearance in murine Klebsiella pneumonia. J. Infect. Dis., 173, 159-165.
23. HARMSEN A. G. (1988): Role of alveolar macrophages in lipopolysaccharide-induced neutrophil accumulation. Infect. Immun., 56, 1858-1863.
24. HASHIMOTO S., PITTET J. F., HONG K., FOLKESSON H., BAGBY G., KOBZIK L., FREVERT C., WATANABE K., TSURUFUJI S. and WIENER-KRONISH J. (1996): Depletion of alveolar macrophages decreases neutrophil chemotaxis to Pseudomonas airspace infections. Am. J. Physiol., 270, L819-L828.
25. HASLETT C. (1999): Granulocyte apoptosis and its role in the resolution and control of lung inflammation. Am. J. Respir. Crit. Care Med., 160, S5-S11.
26. HICKMAN-DAVIS J. M., MICHALEK S. M., GIBBS-ERWIN J. and LINDSEY J. R. (1997): Depletion of alveolar macrophages exacerbates respiratory mycoplasmosis in mycoplasma-resistant C57BL mice but not mycoplasma-susceptible C3H mice. Infect. Immun., 65, 2278-2282.
27. HUFFNAGLE G. B., TOEWS G. B., BURDICK M. D., BOYD M. B., MCALLISTER K. S., MCDONALD R. A., KUNKEL S. L. and STRIETER R. M. (1996): Afferent phase production of TNF-α is required for the development of protective T cell immunity to Cryptococcus neoformans. J. Immunol., 157, 4529-4536.
28. HUSSAIN N., WU F., ZHU L., THRALL R. S. and KRESCH M. J. (1998): Neutrophil apoptosis during the development and resolution of oleic acid-induced acute lung injury in the rat. Am. J. Respir. Cell. Mol. Biol., 19, 867-874.
29. KNAPP S., LEEMANS J. C., MARIS N. A., BRANGER J., VAN ROOIJEN N., FLORQUIN S. and VAN DER POLL T. (2001): Alveolar macrophages protect mice against lethality during Streptococcus pneumoniae pneumonia by attenuating lung inflammation. 41 Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), December 16-29, 2001, Chicago, IL, USA.
30. KOLLS J. K., LEI D., NELSON S., SUMMER W. R., GREENBERG S. and BEUTLER B. (1995): Adenovirus-mediated blockade of tumor necrosis factor in mice protects against endotoxic shock yet impairs pulmonary host defense. J. Infect. Dis., 171, 570-575.
31. KOLLS J. K., LEI D., NELSON S., SUMMER W. R. and SHELLITO J. E. (1997): Pulmonary cytokine gene therapy. Adenoviral-mediated murine interferon gene transfer compartmentally activates alveolar macrophages and enhances bacterial clearance. Chest, 111, 104S.
32. KOLLS J. K., LEI D., STOLTZ D., ZHANG P., SCHWARZENBERGER P. O., YE P., BAGBY G., SUMMER W. R., SHELLITO J. E. and NELSON S. (1998): Adenoviral-mediated interferon-γ gene therapy augments pulmonary host defense of ethanol-treated rats. Alcohol Clin. Exp. Res., 22, 157-162.
33. KOOGUCHI K., HASHIMOTO S., KOBAYASHI A., KITAMURA Y., KUDOH I., WIENER-KRONISH J. and SAWA T. (1998): Role of alveolar macrophages in initiation and regulation of inflammation in Pseudomonas aeruginosa pneumonia. Infect. Immun., 66, 3164-3169.
34. LAICHALK L. L., DANFORTH J. M. and STANDIFORD T. J. (1996): Interleukin-10 inhibits neutrophil phagocytic and bactericidal activity. FEMS Immunol. Med. Microbiol., 15, 181-187.
35. LAICHALK L. L., KUNKEL S. L., STRIETER R. M., DANFORTH J. M., BAILIE M. B. and STANDIFORD T. J. (1996): Tumor necrosis factor mediates lung antibacterial host defense in murine Klebsiella pneumonia. Infect. Immun., 64, 5211-5218.
36. LAUW F., BRANGER J., FLORQUIN S., SPEELMAN P., VAN DEVENTER S. J., AKIRA S. and VAN DER POLL T. (2001): IL-18 improves the early antimicrobial host response to pneumococcal pneumonia. J. Immunol., 168, 372-378.
37. LE J. and VILCEK J. (1987): Tumor necrosis factor and interleukin 1: cytokines with multiple overlapping biological activities. Lab. Invest., 56, 234-248.
38. MOORE T. A., NEWSTEAD M. W., STRIETER R. M., MEHRAD B., BEAMAN B. L. and STANDIFORD T. J. (2000): Bacterial clearance and survival are dependent on CXC chemokine receptor-2 ligands in a murine model of pulmonary Nocardia asteroides infection. J. Immunol., 164, 908-915.
39. MURRAY H. W. (1988): Interferon-γ, the activated macrophage, and host defense against microbial challenge. Ann. Intern. Med., 108, 595-608.
40. OSWALD I. P., WYNN T. A., SHER A. and JAMES S. L. (1992): Interleukin 10 inhibits macrophage microbicidal activity by blocking the endogenous production of tumor necrosis factor alpha required as a costimulatory factor for interferon γ-induced activation. Proc. Natl. Acad. Sci. USA, 89, 8676-8680.
41. RALPH P., NAKOINZ I., SAMPSON-JOHANNES A., FONG S., LOWE D., MIN H. Y. and LIN L. (1992): IL-10, T lymphocyte inhibitor of human blood cell production of IL-1 and tumor necrosis factor. J. Immunol., 148, 808-814.
42. REN Y. and SAVILL J. (1995): Proinflammatory cytokines potentiate thrombospondin-mediated phagocytosis of neutrophils undergoing apoptosis. J. Immunol., 154, 2366-2374.
43. RIJNEVELD A. W., FLORQUIN S., BRANGER J., SPEELMAN P., VAN DEVENTER S. J. H. and VAN DER POLL T. (2001): Tumor necrosis factor-α compensates for the impaired host defense of IL-1 type I receptor deficient mice during pneumococcal pneumonia. J. Immunol. 167, 5240-5246.
44. RIJNEVELD A. W., LAUW F. N., SCHULTZ M. J., FLORQUIN S., TE VELDE A. A., SPEELMAN P., VAN DEVENTER S. J. H. and VAN DER POLL T. (2002): The role of interferon-γ in murine pneumococcal pneumonia. J. Infect. Dis., 185, 91-97.
45. RODRIGUEZ J. L., MILLER C. G., DEFORGE L. E., KELTY L., SHANLEY C. J., BARTLETT R. H. and REMICK D. G. (1992): Local production of interleukin-8 is associated with nosocomial pneumonia. J. Trauma, 33, 74-81, discussion 81-72.
46. RUBINS J. B. and POMEROY C. (1997): Role of gamma Interferon in the pathogenesis of bacteremic pneumococcal pneumonia. Infect. Immun., 65, 2975-2977.
47. SAVILL J., HOGG N., REN Y. and HASLETT C. (1992): Thrombospondin cooperates with CD36 and the vitronectin receptor in macrophage recognition of neutrophils undergoing apoptosis. J. Clin. Invest., 90, 1513-1522.
48. SAWA T., CORRY D. B., GROPPER M. A., OHARA M., KURAHASHI K. and WIENER-KRONISH J. P. (1997): IL-10 improves lung injury and survival in Pseudomonas aeruginosa pneumonia. J. Immunol., 159, 2858-2866.
49. SCHULTZ M. J., RIJNEVELD A. W., FLORQUIN S., EDWARDS C. K., DINARELLO C. A. and VAN DER POLL T. (2002): Role of interleukin 1 in the pulmonary immune response during Pseudomonas aeruginosa pneumonia. Am. J. Physiol. Lung Cell Mol. Physiol., 282, L285-L290.
50. SCHULTZ M. J., RIJNEVELD A. W., SPEELMAN P., DEVENTER S. J. and VAN DER POLL T. (2001): Endogenous interferon-γ impairs bacterial clearance from lungs during Pseudomonas aeruginosa pneumonia. Eur. Cytokine Netw., 12, 39-44.
51. SCHULTZ M. J., WIJNHOLDS J., PEPPELENBOSCH M. P., VERVOORDELDONK M. J., SPEELMAN P., VAN DEVENTER S. J., BORST P. and VAN DER POLL T. (2001): Mice lacking the multidrug resistance protein 1 are resistant to Streptococcus pneuinoniae-induced pneumonia. J. Immunol., 166, 4059-4064.
52. SKERRETT S. J., MARTIN T. R., CHI E. Y., PESCHON J. J., MOHLER K. M. and WILSON C. B. (1999): Role of the type 1 TNF receptor in lung inflammation after inhalation of endotoxin or Pseudomonas aeruginosa. Am. J. Physiol., 276, L715-L727.
53. STANDIFORD T. J., WILKOWSKI J. M., SISSON T. H., HATTORI N., MEHRAD B., BUCKNELL K. A. and MOORE T. A. (1999): Intrapulmonary tumor necrosis factor gene therapy increases bacterial clearance and survival in murine Gram-negative pneumonia. Hum. Gene Ther., 10, 899-909.
54. STEINHAUSER M. L., HOGABOAM C. M., KUNKEL S. L., LUKACS N. W., STRIETER R. M. and STANDIFORD T. J. (1999): IL-10 is a major mediator of sepsis-induced impairment in lung antibacterial host defense. J. Immunol., 162, 392-399.
55. TAKASHIMA K., TATEDA K., MATSUMOTO T., IIZAWA Y., NAKAO M. and YAMAGUCHI K. (1997): Role of tumor necrosis factor alpha in pathogenesis of pneumococcal pneumonia in mice. Infect. Immun., 65, 257-260.
56. TAN A. M., FERRANTE A., GOH D. H., ROBERTON D. M. and CRIPPS A. W. (1995): Activation of the neutrophil bactericidal activity for nontypable Haemophilus influenzae by tumor necrosis factor and lymphotoxin. Pediatr. Res., 37, 155-159.
57. TATEDA K., MOORE T. A., NEWSTEAD M. W., TSAI W. C., ZENG X., DENG J. C., CHEN G., REDDY R., YAMAGUCHI K. and STANDIFORD T. J. (2001): Chemokine-dependent neutrophil recruitment in a murine model of Legionella pneumonia: potential role of neutrophils as immunoregulatory cells. Infect. Immun., 69, 2017-2024.
58. TSAI W. C., STRIETER R. M., MEHRAD B., NEWSTEAD M. W., ZENG X. and STANDIFORD T. J. (2000): CXC chemokine receptor CXCR2 is essential for protective innate host response in murine Pseudomonas aeruginosa pneumonia. Infect. Immun., 68, 4289-4296.
59. TSAI W. C., STRIETER R. M., WILKOWSKI J. M., BUCKNELL K. A., BURDICK M. D., LIRA S. A. and STANDIFORD T. J. (1998): Lung-specific transgenic expression of KC enhances resistance to Klebsiella pneumoniae in mice. J. Immunol., 161, 2435-2440.
60. TSAI W. C., STRIETER R. M., ZISMAN D. A., WILKOWSKI J. M., BUCKNELL K. A., CHEN G. H. and STANDIFORD T. J. (1997): Nitric oxide is required for effective innate immunity against Klebsiella pneumoniae. Infect. Immun., 65, 1870-1875.
61. ULICH T. R., GUO K., YIN S., DEL CASTILLO J., YI E. S., THOMPSON R. C. and EISENBERG S. P. (1992): Endotoxin-induced cytokine gene expression in vivo. IV. Expression of interleukin-1 α/β and interleukin-1 receptor antagonist mRNA during endotoxemia and during endotoxin-initiated local acute inflammation. Am. J. Pathol., 141, 61-68.
62. ULICH T. R., WATSON L. R., YIN S. M., GUO K. Z., WANG P., THANG H. and DEL CASTILLO J. (1991): The intratracheal administration of endotoxin and cytokines. I. Characterization of LPS-induced IL-1 and TNF mRNA expression and the LPS-, IL-1-, and TNF-induced inflammatory infiltrate. Am. J. Pathol., 138, 1485-1496.
63. ULICH T. R., YIN S. M., GUO K. Z., DEL CASTILLO J., EISENBERG S. P. and THOMPSON R. C. (1991): The intratracheal administration of endotoxin and cytokines. III. The interleukin-1 (IL-1) receptor antagonist inhibits endotoxin- and IL-1-induced acute inflammation. Am. J. Pathol., 138, 521-524.
64. VAN DER POLL T., KEOGH C. V., BUURMAN W. A. and LOWRY S. F. (1997): Passive immunization against tumor necrosis factor-α impairs host defense during pneumococcal pneumonia in mice. Am. J. Respir. Crit. Care Med., 155, 603-608.
65. VAN DER POLL T., KEOGH C. V., GUIRAO X., BUURMAN W. A., KOPF M. and LOWRY S. F. (1997): Interleukin-6 gene-deficient mice show impaired defense against pneumococcal pneumonia. J. Infect. Dis., 176, 439-444.
66. VAN DER POLL T., MARCHANT A., KEOGH C. V., GOLDMAN M. and LOWKY S. F. (1996): Interleukin-10 impairs host defense in murine pneumococcal pneumonia. J. Infect. Dis., 174, 994-1000.
67. YE P., RODRIGUEZ F. H., KANALY S., STOCKING K. L., SCHURR J., SCHWARZENBERGER P., OLIVER P., HUANG W., ZHANG P., ZHANG J., SHELLITO J. E., BAGBY G. J., NELSON S., CHARRIER K., PESCHON J. J. and KOLLS J. K. (2001): Requirement of interleukin 17 receptor signaling for lung CXC chemokine and granulocyte colony-stimulating factor expression, neutrophil recruitment, and host defense. J. Exp. Med., 194, 519-527.
68. ZISMAN D. A., STRIETER R. M., KUNKEL S. L., TSAI W. C., WILKOWSKI J. M., BUCKNELL K. A. and STANDIFORD T. J. (1998): Ethanol feeding impairs innate immunity and alters the expression of Th1- and Th2-phenotype cytokines in murine Klebsiella pneumonia. Alcohol Clin. Exp. Res., 22, 621-627.